<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02890550</url>
  </required_header>
  <id_info>
    <org_study_id>5514</org_study_id>
    <nct_id>NCT02890550</nct_id>
  </id_info>
  <brief_title>Clinical Study of a Single Ciliopathy: Alström Syndrome</brief_title>
  <official_title>Clinical Study of a Single Ciliopathy: Alström Syndrome</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Hospital, Strasbourg, France</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University Hospital, Strasbourg, France</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The aim of the study is to characterize the clinical manifestations of ALMS within the
      ciliopathies to prevent complications and determine preventive and therapeutic targets.

      The investigators believe that the clinical consequences of mutations in the gene result
      ALMS1 unprecedented protests and the ALMS study should help to be informed, not only about
      the understanding and decision support other ciliopathies, but also about some common
      diseases, as some physiopathogenic roads could be common; the rare disease being exacerbated
      a model of the channel concerned. Secondarily, the clinical data generated by this project
      will also be used as part of basic research (eg comparison with results in animal models, use
      of human cells for in vitro studies or transcriptomic ....) (which will be a secondary
      upgrading to this work).
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>April 2014</start_date>
  <completion_date type="Anticipated">September 2017</completion_date>
  <primary_completion_date type="Anticipated">September 2017</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Genetic Diagnosis</measure>
    <time_frame>6 months</time_frame>
    <description>In this project, 8 clinical research modules covering major medical issues goshawks ALMS (Genetic diagnosis, neurosensory infringement (ophthalmology and ENT (hearing and olfaction) and neuro-cognitive impairment), obesity &amp; diabetes, endocrine achievement, nephrologic achievement, cardiological achievement, pneumologic achievement, reproductive biology). For each module, the current state of knowledge, clinical issues and their impact on the management of short and medium term ALMS patients are detailed. The clinical complications of this disease must be identified rationally and treatment and clinical management optimized on robust foundations for enhanced medical knowledge. The development of targeted therapies will depend on the clinical research data is the basic foundation of work which can then be enriched by the scientific data currently booming in this area.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Neurosensory infringement</measure>
    <time_frame>6 months</time_frame>
    <description>Ophtalmology study: consultation with visual acuity evaluation, examination at the slit lamp, intraocular pressure measurement, fundus examination, evaluation of Goldmann visual field, rétinophotography, standard and multifocal electroretinography, color vision, Optical Coherence Tomography (OCT), orthoptic balance
proportion of initial macular involvement and impact on future therapeutic trials (eg retina / age thickness)
consequences of low vision on posterior optical channels (including occipital cortex)
Olfaction study: brushing the nasal mucosa, isotopic mucociliary clearance, olfactometry (test UPSIT) gustometry, audiogram, otoacoustic emissions, auditory evoked potentials
Is the origin of deafness endocochlear only?
OAS are they a predictive test and prognosis?
Are ALMS patients suffering anosmia as for other ciliopathies?
Mobile eyelashes respiratory mucosal abnormalities are they like other ciliopathies?</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Neurocognitive impairment</measure>
    <time_frame>6 months</time_frame>
    <description>Neurocognitive explorations:
Neuropsychological assessment with cognitive tests, psychiatric evaluation, MRI, to determine if ALMS patients have cognitive impairment.
Validation of a second population of a new innovative battery of neurocognitive tests for the visually impaired.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Obesity - Diabetes</measure>
    <time_frame>6 months</time_frame>
    <description>Study of the origin of obesity:
Origin central or peripheral obesity?
Determinism of insulin resistance and diabetes? nutrition consultation, impedance, basal calorimetry and OGTT, food investigation over 3 days and dietary questionnaires, laboratory tests, calorimetry, polysomnography (Embletta), abdominal-pelvic MRI</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Endocrine Achievement</measure>
    <time_frame>6 months</time_frame>
    <description>Endocrine study:
- Determine the primary endocrine deficiencies of those who are secondary to obesity and metabolic disorders.
OGTT, test LHRH</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Nephrologic achievement</measure>
    <time_frame>6 months</time_frame>
    <description>Nephrology consultation including water deprivation test and renal ultrasound, to determine what is the primum movens at the renal impairment (glomerular or tubular origin), and if there is a particular component in fibrotic renal disease compared to other ciliopathies.
nephrology consultation, water deprivation test, renal ultrasound</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Cardiological achievement</measure>
    <time_frame>6 months</time_frame>
    <description>Study of cardiovascular risk factors:
- Which patients have cardiac fibrosis? At what age and what connection with possible cardiomyopathy childhood? Cardiology consultation including echocardiogram, electrocardiogram (ECG), ambulatory blood pressure measurement, cardiac MRI, cardiac great vessels holter doppler</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Pneumologic achievement</measure>
    <time_frame>6 months</time_frame>
    <description>Respiratory function study:
Are respiratory alterations related to a breach of mobile eyelashes?
Do ALMS patients develop respiratory fibrosis and in which context ? Spirometry, exhaled NO</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Reproductive biology</measure>
    <time_frame>6 months</time_frame>
    <description>To explain infertility of ALMS patients (men or women)</description>
  </primary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Anticipated">90</enrollment>
  <condition>Alström Syndrome (ALMS)</condition>
  <arm_group>
    <arm_group_label>30 Patients Alström syndrome</arm_group_label>
  </arm_group>
  <arm_group>
    <arm_group_label>60 Related patients Alström syndrome</arm_group_label>
  </arm_group>
  <biospec_retention>Samples With DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      Whole blood, serum, urine, tissue (skin biopsy, adipose tissue)
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        Patients will be recruited through the investigators' consultation Reference Center for
        Rare Diseases in Ophthalmological Genetics (CARGO) or sent by their colleagues from other
        cities including through very geneticists genetic Group or 3rd Thursdays ophthalmologists
        colleagues. Prior consultation CARGO will disclose the medical records of the intention of
        the patient to participate in this research (source document).
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria for Patients with Alström syndrome:

          -  Age&gt; 2 years

          -  Affiliated with a social security scheme

          -  Informed consent signed

          -  Retinal dystrophy and proved at least three diagnostic criteria Alström syndrome
             (Criteria Marshall et al, 2005):

          -  Early obesity

          -  Deafness

          -  Dilated cardiomyopathy

          -  Type 2 diabetes

          -  Hypogonadism

          -  Absence of polydactyly

          -  Lack of mental retardation

          -  A family history of the ALMS

          -  Mutation in the ALMS gene identified

        Inclusion Criteria for Related of Alström patients :

          -  Father / Mother of a patient diagnosed with Alström

          -  Age greater than 18 years

          -  Affiliated with a social security scheme

          -  Informed consent signed

        Exclusion Criteria for Patients with Alström syndrome:

          -  Current pregnancy (a pregnancy test is routinely performed at baseline)

          -  Pregnant or breastfeeding women

          -  Intercurrent diseases do not allow the practice exams in protocol

          -  Subject to exclusion period (determined by a previous study or a study in progress)

        Exclusion Criteria for Related of Alström patients :

          -  Age less than 18 years

          -  Subject to exclusion period (determined by a previous study or a study in progress)
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>2 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Hélène DOLLFUS, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Centre de Référence pour les Affections Rares en Génétique Ophtalmologique (CARGO), Hôpitaux Universitaires de Strasbourg</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Hélène DOLLFUS, MD</last_name>
    <phone>33.3.88.12.81.20</phone>
    <email>helene.dollfus@chru-strasbourg.fr</email>
  </overall_contact>
  <location>
    <facility>
      <name>CMCO, Hôpitaux Universitaires</name>
      <address>
        <city>Schiltigheim</city>
        <zip>67300</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <investigator>
      <last_name>Isabelle KOSCINSKI, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Centre d'Investigation Clinique, Nouvel Hôpital Civil, Hôpitaux Universitaires</name>
      <address>
        <city>Strasbourg</city>
        <zip>67091</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <investigator>
      <last_name>Catherine MUTTER, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Centre de Référence pour les Affections Rares en Génétique Ophtalmologique (CARGO), Hôpitaux Universitaires</name>
      <address>
        <city>Strasbourg</city>
        <zip>67091</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Hélène DOLLFUS, MD</last_name>
      <phone>33.3.88.12.81.20</phone>
      <email>helene.dollfus@chru-strasbourg.fr</email>
    </contact>
    <investigator>
      <last_name>Hélène DOLLFUS, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Clinique Psychiatrique, Hôpital Civil, Hôpitaux Universitaires</name>
      <address>
        <city>Strasbourg</city>
        <zip>67091</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <investigator>
      <last_name>Jack FOUCHER, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Service de Cardiologie, Nouvel Hôpital Civil, Hôpitaux Universitaires</name>
      <address>
        <city>Strasbourg</city>
        <zip>67091</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <investigator>
      <last_name>Patrick OHLMANN, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Service de néphrologie et hémodialyse, Hôpital Civil, Hôpitaux Universitaires</name>
      <address>
        <city>Strasbourg</city>
        <zip>67091</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <investigator>
      <last_name>Bruno MOULIN, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Service de physiologie et des Explorations Fonctionnelles, Nouvel Hôpital Civil, Hôpitaux Universitaires</name>
      <address>
        <city>Strasbourg</city>
        <zip>67091</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <investigator>
      <last_name>Anne CHARLOUX, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Service de Psychothérapie pour Enfants et Adolescents, Hôpital Civil, Hôpitaux Universitaires</name>
      <address>
        <city>Strasbourg</city>
        <zip>67091</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <investigator>
      <last_name>Anne DANION, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Service d'Imagerie 1, Hôpital de Hautepierre, Hôpitaux Universitaires</name>
      <address>
        <city>Strasbourg</city>
        <zip>67098</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <investigator>
      <last_name>Sophie RIEHM, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Service d'ORL et de Chirurgie Cervico-Faciale, Hôpital de Hautepierre, Hôpitaux Universitaires</name>
      <address>
        <city>Strasbourg</city>
        <zip>67098</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <investigator>
      <last_name>Jean-Jacques BRAUN, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Elise GAZZANO, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Service de Génétique Médicale, Hôpital de Hautepierre, Hôpitaux Universitaires</name>
      <address>
        <city>Strasbourg</city>
        <zip>67098</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <investigator>
      <last_name>Hélène DOLLFUS, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Elise SCHAEFFER, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Sylvie ROSSIGNOL, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Service de Médecine Interne, Endocrinologie et Nutrition, Hôpital de Hautepierre, Hôpitaux Universitaires</name>
      <address>
        <city>Strasbourg</city>
        <zip>67098</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <investigator>
      <last_name>Bernard GOICHOT, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Florina LUCA, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Service de Pédiatrie 1, Hôpital de Hautepierre, Hôpitaux Universitaires</name>
      <address>
        <city>Strasbourg</city>
        <zip>67098</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <investigator>
      <last_name>Michel FISCHBACH, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Joëlle TERZIC, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Sylvie SOSKIN, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Service de Radiologie 2, Hôpital de Hautepierre, Hôpitaux Universitaires</name>
      <address>
        <city>Strasbourg</city>
        <zip>67098</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <investigator>
      <last_name>Jean-Louis DIETEMANN, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Stéphane KREMER, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>August 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>August 19, 2016</study_first_submitted>
  <study_first_submitted_qc>August 31, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">September 7, 2016</study_first_posted>
  <last_update_submitted>August 31, 2016</last_update_submitted>
  <last_update_submitted_qc>August 31, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">September 7, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Ciliopathy</keyword>
  <keyword>Retinitis pigmentosa</keyword>
  <keyword>ALMS1 gene</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Syndrome</mesh_term>
    <mesh_term>Alstrom Syndrome</mesh_term>
    <mesh_term>Ciliopathies</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

